OR4F8P

Across TCGA pan-cancer cohorts, OR4F8P RNA is linked to patient survival in 7 of 34 cancer types, making it the most broadly survival-associated OR4F8P data layer.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher OR4F8P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated OR4F8P expression acts as an unfavorable survival marker.

HNSC, KIRC, and SKCM are the cancer types where OR4F8P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	DFS	Tertile	All	0.094	0.710	<.001	105	view →
KIRC	OS	Tertile	All	0.063	0.881	<.001	90	view →
SKCM	OS	Tertile	All	0.216	0.877	<.001	90	view →
PAAD	OS	Tertile	All	0.132	0.590	<.001	36	view →
STAD	DFS	Tertile	All	0.452	0.715	.049	9	view →
THCA	DFS	Tertile	All	0.540	0.841	.001	9	view →
BRCA	OS	Tertile	All	0.277	0.584	.042	6	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

OR4F8P–HNSC (DFS)

Open the HNSC breakdown →